The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Celina G. Kleer

Department of Pathology

Division of Hematology/Oncology

University of Michigan Medical School

Ann Arbor

USA

[email]@umich.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Pathology, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, USA. 2000 - 2009

References

  1. Carcinoma of the breast with medullary-like features: diagnostic challenges and relationship with BRCA1 and EZH2 functions. Kleer, C.G. Arch. Pathol. Lab. Med. (2009) [Pubmed]
  2. CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer. Kleer, C.G., Zhang, Y., Merajver, S.D. Cells. Tissues. Organs. (Print) (2007) [Pubmed]
  3. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Kleer, C.G., Griffith, K.A., Sabel, M.S., Gallagher, G., van Golen, K.L., Wu, Z.F., Merajver, S.D. Breast Cancer Res. Treat. (2005) [Pubmed]
  4. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Kleer, C.G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S.A., Ghosh, D., Sewalt, R.G., Otte, A.P., Hayes, D.F., Sabel, M.S., Livant, D., Weiss, S.J., Rubin, M.A., Chinnaiyan, A.M. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  5. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Kleer, C.G., van Golen, K.L., Zhang, Y., Wu, Z.F., Rubin, M.A., Merajver, S.D. Am. J. Pathol. (2002) [Pubmed]
  6. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Kleer, C.G., Zhang, Y., Pan, Q., van Golen, K.L., Wu, Z.F., Livant, D., Merajver, S.D. Oncogene (2002) [Pubmed]
  7. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Kleer, C.G., Tseng, M.D., Gutsch, D.E., Rochford, R.A., Wu, Z., Joynt, L.K., Helvie, M.A., Chang, T., Van Golen, K.L., Merajver, S.D. Mod. Pathol. (2002) [Pubmed]
  8. Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast. Kleer, C.G., Giordano, T.J., Braun, T., Oberman, H.A. Mod. Pathol. (2001) [Pubmed]
  9. Persistent E-cadherin expression in inflammatory breast cancer. Kleer, C.G., van Golen, K.L., Braun, T., Merajver, S.D. Mod. Pathol. (2001) [Pubmed]
  10. Fine-needle aspiration of breast carcinomas with prominent lymphocytic infiltrate. Kleer, C.G., Michael, C.W. Diagn. Cytopathol. (2000) [Pubmed]
  11. Squamous cell carcinoma of the thyroid: an aggressive tumor associated with tall cell variant of papillary thyroid carcinoma. Kleer, C.G., Giordano, T.J., Merino, M.J. Mod. Pathol. (2000) [Pubmed]
 
WikiGenes - Universities